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Schizophrenia, schizoaffective disorder, and bipolar disorder are common psychiatric disorders with high herita-
bilities and variable phenotypes. The Disrupted in Schizophrenia 1 (DISC1) gene, on chromosome 1q42, was
originally discovered and linked to schizophrenia in a Scottish kindred carrying a balanced translocation that
disrupts DISC1 and DISC2. More recently, DISC1 was linked to schizophrenia, broadly deﬁned, in the general
Finnish population, through the undertransmission to affected women of a common haplotype from the region of
intron 1/exon 2. We present data from a case-control study of a North American white population, conﬁrming
the underrepresentation of a common haplotype of the intron 1/exon 2 region in individuals with schizoaffective
disorder. Multiple haplotypes contained within four haplotype blocks extending between exon 1 and exon 9 are
associated with schizophrenia, schizoaffective disorder, and bipolar disorder. We also ﬁnd overrepresentation of
the exon 9 missense allele Phe607 in schizoaffective disorder. These data support the idea that these apparently
distinct disorders have at least a partially convergent etiology and that variation at the DISC1 locus predisposes
individuals to a variety of psychiatric disorders.
Introduction
Schizophrenia (MIM 181500) and bipolar disorder are
complex psychiatric disorders affecting ∼1.8% of the
population worldwide (Sklar 2002). Family and twin
studies have shown that there is a strong genetic com-
ponent to these psychiatric diseases. Both disorders dem-
onstrate complex patterns of inheritance and variable
phenotypes. Linkage studies have identiﬁed multiple
regions as potential susceptibility loci, with little or no
overlap between the loci for each of the two disorders
(Sklar 2002). However, chromosome 1q42 was initially
identiﬁed as a possible site for a schizophrenia suscep-
tibility locus in a large Scottish kindred exhibiting a wide
spectrum of psychiatric disorders (St. Clair et al. 1990).
In this family, a balanced (1;11)(q42.1;q14.3) translo-
cation was shown to cosegregate with schizophrenia and
other psychiatric disorders. Two novel genes, Disrupted
in Schizophrenia 1 and 2 (DISC1 [MIM 605210] and
DISC2 [MIM 605271]), were observed to be disrupted
by the translocation (Millar et al. 2000, 2001; Black-
wood et al. 2001). Analysis of other independent Scot-
tish families with schizophrenia and bipolar disorder,
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using intragenic SNPs, failed to show signiﬁcant asso-
ciation between disease and these two genes (Devon et
al. 2001). However, linkage of a microsatellite marker
located within the DISC1 gene to disease in families
from the general Finnish population conﬁrmed the 1q42
region as a potential susceptibility locus (Hovatta et al.
1999; Ekelund et al. 2001).
The DISC1 protein is a multifunctional protein ca-
pable of protein-protein interactions via distinct func-
tional domains (Millar et al. 2003; Morris et al. 2003;
Ozeki et al. 2003; Brandon et al. 2004). The inferred
sequence of DISC1 predicts a secondary structure with
a globular N-terminal region and a coil-coil C-terminus.
In terms of function, two microtubule-binding proteins,
MAP1A (MIM 600178) and MIPT3 (MIM 607380),
interact with DISC1 through two separate domains in
the N-terminal half of the DISC1 protein. NUDEL
(MIM 607538) and NUDE, centrosome-associated pro-
teins, interact with DISC1 through a C-terminal domain
in DISC1 that is lost as a result of the truncation seen
in the original Scottish family. In addition, the tran-
scription factors ATF4 (MIM 604064) and ATF5 (MIM
606398) bind to the C-terminus of DISC1. Through
these multiple interactions, DISC1 appears to be a com-
ponent of the intracellular machinery that integrates
multiple functions, including intracellular transport,
neuronal migration and architecture, neuronal cell sig-
naling, and gene expression. Alteration of the function-
ing of such a multifunctional protein would be expected
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to lead to pleiotropic molecular effects dependent on
the location and type of sequence change and on the
functional status of the different components of intra-
cellular functions in which DISC1 plays a role. Such
mechanisms are capable of explaining how pleiotropy
of phenotypic expression leads to different clinical dis-
eases. In addition, pleiotropy may result from altera-
tions in functions of neuronal networks with roles in
diverse behaviors—the ﬁnal behavioral phenotype rep-
resenting the integrated expression of the functioning
of different brain circuits within a developmental tra-
jectory and environmental context. These phenomena
help account for both single-gene pleiotropy (different
sequence variants of a gene may have different effects)
and single-locus pleiotropy (the same sequence variant
may have various effects). The Scottish family identiﬁed
by Blackwood et al. (2001) demonstrated single-locus
pleiotropy weighted toward recurrent major depression,
but other sequence variants within DISC1 might be ex-
pected to result in different disease proﬁles.
In a family-based study using broad diagnostic cri-
teria, Hennah et al. (2003) reported the undertrans-
mission of a common haplotype to affected women in
the general Finnish population. In the present study, we
report data obtained from a case-control data set of
white individuals from North America. Our data sup-
port the ﬁnding of undertransmission of a common hap-
lotype at the 5′ end of the DISC1 gene, but we also ﬁnd
evidence of association of schizophrenia, schizoaffective
disorder, and bipolar disorder with multiple haplotypes
contained within four blocks extending between exon
1 and exon 9. In particular, we ﬁnd a strong association
between a missense variant in exon 9 and schizoaffective
disorder. These data suggest a generalized role for
DISC1 mutations in psychiatric disease in which the
phenotypic outcome is determined in part by the nature
of the alteration in the DISC1 gene and in part by the
effects of other modifying loci and the environment.
Methods
Diagnosis and Subject Recruitment
Subjects were recruited from the clinical services of
the Zucker Hillside Hospital, a division of the North
Shore–Long Island Jewish Health System (NSLIJHS).
After giving written informed consent to an NSLIJHS
institutional review board–approved human-research
protocol, each subject was assessed with the Structured
Clinical Interview for DSM-IV Axis I Disorders (SCID,
version 2.0). All SCID interviews were conducted by
trained raters whose reliability was conﬁrmed by an
expert diagnostician’s observation of a minimum of
three interviews. The subject’s report during the struc-
tured interview, current inpatient medical records, past
records (when available), and collateral information
from family members were then used to rate the SCID
score. Data were then compiled by the interviewer into
a detailed narrative case summary. These summaries in-
cluded information in regard to the onset and course of
axis I disorders, presence of any axis II pathology that
may have contributed to symptom presentation, any axis
III diagnoses, and a brief description of the subject’s
psychosocial and occupational functioning during the
course of their illness. The interviewer then presented
the resulting case summary to a consensus diagnostic
committee that comprises a minimum of three senior
faculty with DSM-IV diagnostic expertise. In addition,
the committee includes junior faculty, residents, fellows,
graduate students, and other trained SCID raters. After
the presentation of the case summary to the committee,
each case was discussed to arrive at the consensus DSM-
IV diagnosis. All participants were North American
white individuals of European origin. The total sample
of 586 individuals was composed of 217 healthy con-
trols (90 male, 127 female; mean age 46.3 years), 196
subjects diagnosed with schizophrenia (141 male, 55 fe-
male; mean age 39.1 years), 82 subjects with bipolar
disorder (43 male, 39 female; mean age 33.7 years), and
62 subjects with schizoaffective disorder (33 male, 29
female; mean age 39.8 years).
Genotyping
A total of 39 SNP loci were genotyped by 5′-exonu-
clease assay. Thirty-ﬁve primer-probe sets were obtained
as Taqman Assays-on-Demand (Applied Biosystems).
Four primer-probe sets corresponding to missense var-
iants reported in the dbSNP database (build 119) were
designed using Assays-by-Design software (ABI). Ge-
nomic DNA (5 ng) was ampliﬁed on a 9700 thermo-
cycler (ABI). At the end point of ampliﬁcation, genotypes
were discriminated using SDS 2.0 software on an Ap-
plied Biosystems 7900 Analyzer. For ampliﬁcation, ini-
tial incubation was at 95C for 10 min, followed by 40
cycles at 92C (15 s) and 60C (1 min). All assays suc-
cessfully discriminated three genotypes for each biallelic
marker. Genotyping accuracy was assessed by regeno-
typing one in six samples, randomly selected, which
produced an overall accuracy 199%; genotyping com-
pleteness was 10.99. Haplotype block structure was
determined using the Haploview program (J. C. Barrett
and M. Daly; see Haploview Web site). Blocks were de-
ﬁned in accordance with the criteria of Gabriel et al.
(2002), but the criterion for pairwise linkage disequilib-
rium (LD) betweenmarkers was relaxed from an average
D′ 195% to an average D′ 190% within a block. Hap-
lotypes were assigned to individuals by use of PHASE
2.02 (Stephens et al. 2001; Stephens and Donnelly
2003). Individuals with incomplete genotyping data
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were excluded from haplotype analyses to prevent pos-
sible distortion of haplotype frequencies by the pro-
gram’s inference of absent genotypes.
Statistical Methods
Nonparametric testing for signiﬁcance values for al-
lelic and genotypic association was performed using a
standard x2 test. Haplotype association was evaluated
using the more stringent Fisher exact test, because hap-
lotype frequencies sometimes equaled zero. (Note that
it is the number of haplotypes expected that determines
suitability for x2 analysis, not the frequency observed).
Bonferroni correction was not applied, because the seven
DISC1 haplotype regions do not meet the criterion of
independence. First, they are regions of the same gene,
and, in fact, our data indicate that there may be more
than one linkage signal corresponding to more than one
functional locus at the gene. Second, pairwise LD values
(see ﬁg. 1B) indicate some evidence of extended LD (i.e.,
nonindependence) across haplotype-block boundaries.
Results
We genotyped 39 SNPs (table 1) that span the 410-kb
DISC1 gene from exon 1 to exon 13. Each marker was
analyzed by x2 analysis for allelic and genotypic asso-
ciation with schizophrenia, schizoaffective disorder, and
bipolar disorder (table 1). Five markers—rs2812393,
rs1322784, rs1322783, rs2255340, and rs2738864—
show signiﬁcant allelic association with schizophrenia
( , .013, .047, .006, and .005, respectively). APp .048
single marker, rs6675281, shows signiﬁcant allelic as-
sociation with schizoaffective disorder ( ).Pp .0000023
Five markers—rs1322784, rs2255340, rs2738864, and
hCV1650723, all of which also show allelic association,
and hCV9628138—show genotypic association with
schizophrenia ( , .016, .012, .003, and .037,Pp .008
respectively. Four markers—rs6675281 (which also
shows allelic association), hCV1650713, rs999710, and
hCV1650723—show genotypic association with schi-
zoaffective disorder.
The DISC1 haplotype block structure (individual
blocks being termed haploblocks) was determined sep-
arately for control and affected groups. Conservatively,
seven blocks were identiﬁed across DISC1 in controls
(ﬁg. 1B). This block structure is altered within block 3
in individuals with schizophrenia. Marker rs6675281
(Leu607Phe) is in strong LD with neighboring markers
in controls but not in individuals with schizophrenia or
bipolar disorder (data not shown).
Figure 2A–2D shows common haplotypes for hap-
loblocks 1–4, together with the haplotype frequency for
the control group and for each case group (haplotypes,
frequencies, and case/control numbers shown in table
2). Of the seven blocks we identiﬁed, four carried hap-
lotypes that were underrepresented either in cases or in
controls. Block 1 (ﬁg. 2A) revealed a common haplotype
(hap1) that was underrepresented only in patients with
schizoaffective disorder ( ). Similarly, a com-Pp .013
mon haplotype (hap1) in block 3 (ﬁg. 2C) was also
underrepresented in patients with schizoaffective dis-
order ( ). Block 1 and block 3 overlap the hap-Pp .015
lotype blocks HEP3 and HEP1, respectively, reported
elsewhere (Hennah et al. 2003). HEP3 was reported to
be undertransmitted to affected females in the broadest
liability class, whereas HEP1, which carries the T allele
of SNP rs6675281 (Phe607), was overtransmitted (Hen-
nah et al. 2003) (ﬁg. 1A and 1B). In block 1 (ﬁg. 2A),
two haplotypes (hap8 and hap14) showed association
to schizophrenia ( and .0095, respectively) andPp .021
schizoaffective ( and .001) and bipolar (Pp .047 Pp
and .0192) disorders. In block 1, hap7 was absent.0192
from the bipolar group but showed association with
schizophrenia ( ) and schizoaffective disorderPp .045
( ). In individuals with schizophrenia, twoPp .047
common haplotypes in block 2 (ﬁg. 2B) were distorted
in their distribution between cases and controls. In hap-
loblock 2, hap3 showed signiﬁcant association with dis-
ease ( ), but hap4 (21111) was signiﬁcantly un-Pp .025
derrepresented in schizophrenic patients ( ). InPp .021
haploblock 3 (ﬁg. 2C), two haplotypes (hap3 and hap8)
show association with schizoaffective disorder (Pp
and .000054, respectively). In haploblock 4 (ﬁg..00045
2D), two haplotypes show association with disease—
hap8 with bipolar disorder ( ) and hap9 withPp .0048
schizophrenia ( ). It should be noted that a com-Pp .03
mon haplotype (hap1) in haploblock 4 was also un-
derrepresented in patients with bipolar disorder (Pp
) (ﬁg. 2D)..027
With the exception of the allelic ( )Pp .000027
and genotypic ( ) associations of markerPp .0066
rs6675281 and of hap3 and hap8 in haploblock3
( and .0057, respectively) with schizoaffectivePp .047
disorder, none of the observed associations remains sig-
niﬁcant if the Bonferroni correction—highly conserva-
tive, given the LD in the DISC1 region—is made. These
observations remain suggestive of association of DISC1
variation with schizophrenia, schizoaffective disorder,
and bipolar disorder.
Discussion
The translocation in the original Scottish family dem-
onstrated that disruption of the DISC1 gene, although
sufﬁcient to predispose an individual to psychiatric dis-
orders, was, in itself, insufﬁcient to predict any particular
disorder. The majority of affected individuals within the
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Figure 1 A, Schematic of the DISC1 gene, showing the 13 exons and the relative positions of the 39 SNP markers and haplotype blocks.
HEP1 and HEP3 are the haplotype blocks identiﬁed by Hennah et al. (2003). B, Haploview-generated LD map of the DISC1 gene in North
American white controls. Regions of high LD (D′ p 1 and ) are shown in bright red. Markers with lower LD (D′ ! 1 and )LOD 1 2 LOD 1 2
are shown in red through pink (color intensity decreases with decreasing D′ value). Regions with high LD but low informativeness (D′ p 1
and ) are shown in blue. Regions of low LD and low LOD scores (D′ ! 2 and ) are shown in white. Seven haplotype blocksLOD ! 2 LOD ! 2
are identiﬁed in which average D′ 1 0.90.
Scottish kindred were affected with recurrent major de-
pression, and some individuals carrying the transloca-
tion had no diagnosed psychiatric disorder. The Finnish
study, which detected undertransmission of HEP3 (a
haplotype encompassing the whole of block 1 deﬁned
in our study), used a broad phenotype for the haplotype
analysis that included schizophrenia, schizoaffective dis-
order, and schizophrenia spectrum diagnosis, as well as
bipolar disorder and major depression. In the present
study, we analyzed the disease classes separately and
have shown that, for haploblock 1 (HEP3 from Hennah
et al. [2003]), the signal for underrepresentation/under-
transmission of the most common haplotype is solely
derived from the individuals with schizoaffective dis-
order, in our population (ﬁg. 2). In both the Finnish
study (Hennah et al. 2003) and our study, the under-
transmitted haplotype carries the A allele of marker
rs3738401, suggesting that the haplotype involved may
be the same in both cases.
The associations we have identiﬁed are unlikely to
have arisen as a result of any admixture within our test
group, in part because they are congruent with results
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Table 1
Allele-Based and Genotype-Based Association with Schizophrenia, Schizoaffective Disorder, and Bipolar Disorder,
Showing the Celera SNP and dbSNP Identiﬁers for Each Genotyping Marker
CELERA SNP dbSNP
ASSOCIATION P VALUEa
CODING CHANGE
ALLELE FREQUENCY
RISK RATIOAllelic Genotypic Controls Cases
hCV27474272 rs3738400 … … Gly5Met … … …
hCV12001977 rs1895225 … … … … … …
hCV12001946 rs1572899 … .048c … .298 .397 1.185
hCV12001945 rs1538975 … … … … … …
hCV25641899 rs3738401 … … Gln264Arg … … …
hCV12001940 rs1954175 … … … … … …
hCV9626784 rs1340982 … … … … … …
hCV16113533 rs2812379 … … … … … …
hCV16114160 rs2793094 … … … … … …
hCV12001932 rs1538977 … … … … … …
hCV16114126 rs2793101 … … … … … …
hCV16113570 rs2812393 .048b … … .336 .404 1.203
hCV12001930 rs1322784 .013b .008b … .680 .759 1.117
hCV12001929 rs1322783 .047b … … .849 .899 1.059
hCV1650649 rs2255340 .006b .016b … .702 .787 1.121
hCV1650650 rs2738864 .005b .012b … .700 .787 1.125
hCV1650657 rs1407598 … .046d … .198 .227 1.150
hCV1650667 rs6675281 .0000023c .000056c Leu607Phe .132 .319 2.417
hCV1650669 rs1407598 … .039d … .195 .221 1.133
hCV9627536 rs1535529 … .035d … .200 .221 1.106
hCV1650688 rs1000731 … … … … … …
hCV1650709 rs734551 … … … … … …
hCV1650713 … … .024c … .337 .327 1.031
hCV9628231 rs999710 … .003c … .691 .612 1.129
hCV1650723 … .01b .003b,c … .309 .410 1.326
hCV9628176 rs821723 … … … … … …
hCV1650750 rs2038636 … … … … … …
hCV1650754 rs821717 … … … … … …
hCV1433206 rs821577 … … … … … …
hCV9628138 … … .037b … .477 .527 1.106
hCV9628093 rs1417866 … … … … … …
hCV9628061 rs821592 … … … … … …
hCV1433188 rs821597 … … … … … …
hCV1433174 rs821653 … … … … … …
hCV9627519 rs843979 … … … … … …
hCV1433135 rs821616 … … Cys704Ser … … …
hCV1433111 rs3524 … .037d … .498 .617 1.240
hCV26095 rs2806465 … … … … … …
hCV9626960 rs1411776 … … … … … …
NOTE.—Allele frequencies and risk ratios are given for markers showing association.
a Signiﬁcant P values are shown for individual genotypes at each locus.
b Association with schizophrenia.
c Association with schizoaffective disorder.
d Association with bipolar disorder.
from the Finnish population and do not reﬂect DSC1
allele-frequency differences between populations (U.S.
whites and African-Americans) we have observed. This
problem will also be deﬁnitively resolved by genotyping
a large genomic control panel across the case and con-
trol samples in this data set.
In the Finnish population, a later reanalysis of data
supporting the association of HEP1 (corresponding to
haploblock 3 deﬁned in our study) with disease sug-
gested that the initial association resulted from a linkage
artifact (Hennah et al. 2003). However, in our popu-
lation, we have found a strong association of two psy-
chiatric disorders—bipolar disorder and schizoaffective
disorder—with the T-allele (Phe607) SNP rs6675281
and the haplotypes carrying it (ﬁg. 2C), including the
most common haplotype (hap3; frequency 110%),
which shows signiﬁcant association with schizoaffective
disorder. This data was obtained using only individuals
for whom all necessary genotyping information was
available, to avoid the problems that arise due to the
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Figure 2 Schematic of common haplotypes and of haplotypes showing signiﬁcant association with disease, in haploblocks 1, 2, 3, and 4
(major alleles [unshaded] and minor alleles [shaded]). Haplotype frequencies for controls and for patients with schizophrenia (Sz), schizoaffective
disorder (SA), and bipolar disorder (BP) are shown below the diagrams. Amino acid changes are shownwithin the given haplotypes for haploblock
1 (Gln264Arg) and haploblock 3 (Leu607Phe). * . ** .P ! .05 P ! .01
inference of missing data. The most common haplotype
carrying this allele shows association only with schi-
zoaffective disorder, and this may explain the failure of
the original HEP1 observation to pass the validation
tests performed (Hennah et al. 2003).
Both hap3 and hap8 of block 3 carry Phe607. The
effect of this amino acid substitution on protein function
is currently unknown. The human DISC1 polypeptide
has an overall amino acid identity to the mouse and rat
sequences of 55.2% and 52.2%, respectively (Ma et al.
2002). Leu607 is the ancestral allele and is conserved
across the mouse (Mus musculus), rat (Rattus norveg-
icus), pufferﬁsh (Fugu rubripes), and zebraﬁsh (Danio
rerio). Such sequence conservation across an evolution-
ary time frame of 1100 million years suggests functional
signiﬁcance of the Leu607Pro polymorphism found in
the human. Furthermore, Leu607 lies within the regions
identiﬁed as necessary for binding NUDEL, MIPT3,
ATF4, and ATF5. Leu607 also lies at the end of a pu-
tative leucine zipper domain, although the function of
this putative domain is unknown, and the sequences
encoding it are absent from an alternatively spliced mu-
rine mRNA. Of the three other missense variants listed
in the public database (Gly5Met, Gln264Arg, and
Cys704Ser), only Gly5 is conserved among humans, ro-
dents, and pufferﬁsh (Ma et al. 2002). We identiﬁed the
Met5 allele in an Asian/Paciﬁc islander population at a
frequency of !3% (data not shown). Rats and mice
carry a serine residue at the position corresponding to
human residue 704 and carry a threonine at the position
corresponding to human residue 264 (Ma et al. 2002;
Taylor et al. 2003).
Schizophrenia and bipolar disorder are generally con-
sidered to be separate entities, but patients who exhibit
multiple symptoms of both disorders are often given the
hybrid diagnosis of schizoaffective disorder (Blacker
and Tsuang 1992). This has helped give rise to the ar-
gument that schizophrenia and bipolar disorder are var-
iant expressions of a diathesis, in part because of the
similar disease frequencies, ages at onset, and absence
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Table 2
Common DISC1 Haplotypes in Cases and Controls
BLOCK AND
HAPLOTYPE
NUMBER HAPLOTYPE FREQUENCY
NO. OF INDIVIDUALS
Controls Schizophrenia
Schizoaffective
Disorder
Bipolar
Disorder Total
Block 1:
1 12211 .60 261 205 57 96 619
2 12212 .02 7 3 4 5 19
4 12222 .03 15 8 2 2 27
7 11211 .01 0 4 2 0 6
8 11221 .01 0 5 2 3 10
11 22211 .01 4 6 3 2 15
14 22112 .01 0 6 3 3 12
18 21111 .01 4 6 0 1 11
19 21121 .01 2 3 1 0 6
20 21122 .27 112 95 36 37 280
All … … 412 354 114 152 1,032
Block 2:
3 12122 .37 100 144 46 59 349
4 21111 .12 51 36 17 15 119
5 21122 .03 7 12 3 4 26
6 21211 .12 46 35 15 23 119
8 22111 .01 0 4 0 1 5
9 22122 .34 114 128 31 54 327
All … … 320 362 114 158 954
Block 3:
1 12121 .48 210 176 43 72 501
2 12122 .15 68 54 13 20 155
3 11121 .16 55 53 32 28 168
7 22212 .20 81 73 23 33 210
8 21212 .01 0 2 5 2 9
All … … 418 362 116 156 1,052
Block 4:
1 1112 .16 67 44 20 13 144
2 1111 .12 51 31 7 18 107
4 1212 .06 25 18 2 12 57
5 1222 .32 117 89 37 47 290
6 2112 .32 130 86 28 47 291
7 2111 .01 0 2 0 4 6
10 2222 .02 3 8 3 1 15
NOTE.—Haplotypes were generated using data from individuals with complete genotype information within
a block.
of sex bias of the two disorders. Supporting this theory
are studies that have linked theG72/G30 locus at 13q33
to both bipolar disorder (Hattori et al. 2003; Chen et
al. 2004) and schizophrenia (Chumakov et al. 2002;
Schumacher et al. 2004) and that have linked bipolar
disorder to 22q11-13 and to 8p22, 10p14, and 18p11.2,
regions previously linked to schizophrenia (Gill et al.
1996; Blouin et al. 1998; Faraone et al. 1998; Schwab
et al. 1998, 2000; Straub et al. 1998; Detera-Wadleigh
et al. 1999; Berrettini 2000, 2003; Foroud et al. 2000;
Ophoff et al. 2002). In addition, possible common risk
loci for the two disorders have been identiﬁed on chro-
mosomes 4p16 and 3q27 (Bailer et al. 2002; Als et al.
2004). The argument of shared neurobiology is also
supported by the effectiveness of antipsychotic drugs in
the treatment of psychotic symptoms of both disorders
(Adler and Strakowski 2003; Sundram et al. 2003).
Countering this argument is the genetic epidemiological
data (Badner and Gershon 2002; Sklar 2002; Levinson
et al. 2003; Lewis et al. 2003; Segurado et al. 2003),
which show little or no evidence for cosegregation of
schizophrenia and bipolar disorder in families, although
families both of patients with schizophrenia and of pa-
tients with bipolar disorder are at increased risk for
schizoaffective disorder and unipolar depression (Baron
2001). Also, the two disorders show marked differences
in their responses to lithium, anticonvulsants, and an-
tidepressants. Imaging studies and postmortem analyses
have shown altered neurostructure, with reduced brain
weight and increased ventricular cerebrospinal ﬂuid
suggestive of cortical atrophy, seen only in schizophre-
nia and not in bipolar or the affective disorders. Indeed,
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it has been demonstrated in the parahippocampal region
of individuals with schizophrenia that there is cytoar-
chitectural disorganization of the entorhinal region,
with too few neurons in the superﬁcial layers and too
many neurons in the deeper layers (Jakob and Beck-
mann 1986; Arnold et al. 1991), and that there is a
similar laminar shift in the cingulated cortex, suggesting
a generalized failure of neurons to migrate and settle in
the appropriate cortical locations (Benes et al. 1991;
Akbarian et al. 1993). Our data suggest that the pres-
ence of particular haplotypes at the 5′ end of the DISC1
gene may predispose individuals to any of these three
psychiatric disorders. Three haplotypes in haploblock
1 showed association with all three disorders (hap7 was
not represented in the group with bipolar disorder and
therefore showed no association).
As discussed above, there are candidate functional
variants of DISC1. However, the identity of the func-
tional DISC1 variant(s) that may be predisposing to
psychiatric disease is still unknown. The effects of dis-
rupting DISC1 in the original Scottish family appear to
arise as a result of haploinsufﬁciency rather than loss
of function, since none of the members of the family
were reported to be homozygous for the translocation,
although a possible dominant negative mechanism can-
not be ruled out. Therefore, in addition to mutations
that affect protein function, any mutation or polymor-
phism that affects the rate at which the DISC1 gene is
transcribed might also be expected to predispose an in-
dividual to disease. It is possible that the predisposing
haplotypes identiﬁed in blocks 1 and 2 are also asso-
ciated with lower levels of transcription as a result of
changes in putative intronic enhancer elements. An al-
ternative is that the associating haplotypes may carry
currently unknown missense or nonsense mutations in
the coding sequence. These possibilities can be resolved
by pulse-chase experiments to determine transcription-
al activity and by resequencing. The strongest associa-
tion of a DISC1 haplotype with disease was in haplo-
block 3, in which haplotypes carrying the allele encod-
ing Phe607—in place of the evolutionarily conserved
Leu607 within the third leucine zipper domain—
show strong association with schizoaffective disorder.
Leu607Phe could affect DISC1 interactions with mul-
tiple proteins, because this residue is a constituent of
multiple-binding domains: NUDEL, MAP1A, ATF4,
and ATF5. However, the functional signiﬁcance of
Leu607 is currently unknown. The DISC2 gene over-
laps DISC1 and is thought to encode a nontranslated
mRNA. DISC2 is also disrupted in the translocation
observed in the Scottish family. The function of this gene
is unknown, but marker rs6675281—which shows ro-
bust association with schizoaffective disorder—also lies
within DISC2, and it can be argued that marker
rs6675281 could be in strong LD with an important
DISC2 polymorphism. The haplotype block HEP1
(Hennah et al. 2003) showed suggestive association
with schizophrenia and also encompassed portions of
both DISC1 and DISC2. The presence of a coding poly-
morphism in DISC1 makes this gene the leading can-
didate, but a functional consequence of the Leu607Phe
transition needs to be demonstrated or an as-yet un-
known missense or splicing variant needs to be identi-
ﬁed by resequencing for this possibility to be conﬁrmed.
The converging data from multiple studies suggest
that all three disorders—schizophrenia, schizoaffective
disorder, and bipolar disorder—have an overlapping
root in altered DISC1 function or expression, but it is
possible that different variants within the DISC1 gene
determine variation in phenotype through correspond-
ing variation in interactions with DISC1’s binding part-
ners. It should also be noted that, with the exception
of block 1, there is only an association overlap between
schizoaffective disorder and bipolar disorder. This raises
the possibility that different mechanisms involving
DISC1 can cause schizophrenia and to bipolar and schi-
zoaffective disorders.
Brain imaging (Weinberger and Lipska 1995) and
neuroanatomical data (Jakob and Beckmann 1986; Ar-
nold et al. 1991; Benes et al. 1991) suggest that schizo-
phrenia arises from an early neuronal deﬁcit leading to
aberrant folding of the cortical regions. Studies of
DISC1 protein expression in rodents have indicated that
its expression is developmentally regulated, with the
highest expression during late embryogenesis (Ozeki et
al. 2003). Loss of DISC1 expression in early brain de-
velopment or loss of the ability of DISC1 to bind NU-
DEL, whose gene is known to be associated with dis-
eases of cortical development (reviewed by Ross and
Walsh [2001]), allows us to propose a neurodevelop-
mental model for the role of DISC1 in the development
of schizophrenia. In this model, NUDEL-mediated mi-
crotubule organization is altered because of reduced
DISC1 binding. The defect in microtubule function
leads to deﬁcits in neuronal migration, axonal exten-
sion, and neurite outgrowth. Reduced neurite out-
growth has been shown in cultured PC12 cells express-
ing mutant forms of DISC1 (Ozeki et al. 2003). The
affective disorders and bipolar disorder, which exhibit
none of the structural alterations seen in the brains of
patients with schizophrenia, may arise solely as a result
of disruption of DISC1 protein-protein interactions in
mature neurons. For these intriguing possibilities to be
resolved, it will be necessary to identify the exact nature
of DISC1 alterations in affected individuals and to
model those changes both in tissue culture, in which
changes in protein-protein interaction can be evaluated,
and in knockout mice, in which the developmental im-
plications of particular DISC1 alleles can be determined.
Given the heterogeneity of phenotypes in all three dis-
870 Am. J. Hum. Genet. 75:862–872, 2004
ease classes, it is also possible that alterations in DISC1
function or expression account for only a fraction of
cases observed and that other mechanisms can give rise
to similar phenotypes.
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